Health ❯ Healthcare ❯ Medical Research

Cardiology

Heart Failure Atrial Fibrillation Hypertrophic Cardiomyopathy Heart Diseases Blood Pressure Measurement Antiplatelet Therapy Stem Cell Therapy Cardiac Arrhythmias Clinical Trials Cardiac Development

Evolocumab Cuts First Cardiovascular Events by 31% in High‑Risk Diabetes Without Known Atherosclerosis

The ACC 2026 analysis signals earlier, more aggressive LDL cholesterol lowering could reshape primary prevention for patients with diabetes.

MRI T2 Mapping Yields Non-Invasive Measure of Heart Failure Severity, Study Finds

University of Michigan AI Detects Microvascular Heart Disease From a 10-Second EKG

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

Randomized Trial Finds Daily Coffee Cuts AFib Recurrence by 39%

Early Stem Cell Infusion After First Heart Attack Cuts Heart Failure Risk in Phase 3 Trial

Spatiotemporal Atlas Charts Early Human Heart Development, Reveals Human-Specific Adrenaline Cells

TCT 2025: Stent‑Sparing Balloons Match DES at One Year as Lower‑Cost Alternatives Rival IVL

AstraZeneca’s Baxdrostat Hits Phase 3 Goal With 24‑Hour Blood‑Pressure Cuts

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

AI Analyzes Full Medical Records to Personalize Anticoagulant Use in Atrial Fibrillation

AI Stethoscope Spots Heart Failure, Atrial Fibrillation and Valve Disease in 15 Seconds, NHS Trial Finds

TACSI Trial Finds No Benefit of Dual Antiplatelet Therapy After CABG, Higher Bleeding Risk

Cheek Swab Shows Early Promise for Detecting Arrhythmogenic Cardiomyopathy in Children

Major Trial Finds Post-Heart Attack Beta-Blockers Unnecessary for Most, With Added Risk for Women

CBT and Exercise Show Short-Term Gains in First Trial for 'Broken-Heart' Syndrome

Irregular Sleep Tied to Higher Short-Term Risk After Heart Failure, Small Study Finds

Cambridge Researchers Pinpoint Why Arm Cuff Tests Underestimate Systolic Blood Pressure

Biomarker-Enhanced CHA2DS2-VASc Score Personalizes Stroke Prevention in Atrial Fibrillation

FDA Clears AI Model to Screen for Cardiac Amyloidosis